Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$30.58 -0.17 (-0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) EV to EBIT (2019 - 2026)

Updated

Lakefront Biotherapeutics' (LKFT) EV to EBIT stood at 4.22 in the quarter ended Jun 30, 2026, up 0.9% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) EV to EBIT (2019 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Lakefront Biotherapeutics' EV to EBIT came in at 6.17.

  • Quarterly EV to EBIT has ranged from -10.40 in the quarter ended Mar 31, 2024 to 21.24 in the quarter ended Sep 30, 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lakefront Biotherapeutics 2.01 Bn 2.01 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.22
Mar 31, 2026 -3.17
Dec 31, 2025 -3.78
Jun 30, 2024 224.26
Jun 30, 2020 17.52
Mar 31, 2020 15.20
Dec 31, 2019 16.88
Sep 30, 2019 4.94
API Access

Lakefront Biotherapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=LKFT&period=max&api_key=YOUR_API_KEY